Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
West Pharmaceutical Services, Inc. (WST) had Debt to Capital Ratio of 0.06 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$804.60M |
|
$140.00M |
|
$510.30M |
|
$294.30M |
|
$637.00M |
|
$167.60M |
|
$4.30M |
|
$171.90M |
|
$171.90M |
|
$137.90M |
|
$140.00M |
|
$140.00M |
|
$137.90M |
|
$167.60M |
|
$210.60M |
|
72.20M |
|
72.60M |
|
$1.94 |
|
$1.92 |
|
| Balance Sheet Financials | |
$1.82B |
|
$1.74B |
|
$2.28B |
|
$4.11B |
|
$635.40M |
|
$202.70M |
|
$418.90M |
|
$1.05B |
|
$3.05B |
|
$2.93B |
|
$3.05B |
|
71.90M |
|
| Cash Flow Statement Financials | |
$503.70M |
|
$-209.80M |
|
$-173.40M |
|
$484.60M |
|
$628.50M |
|
$143.90M |
|
$17.10M |
|
$-45.40M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.87 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.06 |
0.07 |
|
36.58% |
|
20.83% |
|
20.83% |
|
-- |
|
21.36% |
|
17.40% |
|
$293.90M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
1.17 |
|
1.29 |
|
69.91 |
|
4.59% |
|
4.77% |
|
3.41% |
|
4.30% |
|
$42.44 |
|
$4.05 |
|
$6.94 |
|